Marine Biologics' phycologist Fanny Lalegerie prepares macroalgae samples for analysis at the company laboratory in Roscoff, Brittany © Marine Biologics
In partnership with three Alaskan kelp farms - Spruce Island Farms, Alaska Ocean Farms, and Alaska Sea Greens – Marine Biologics seeks to use this new funding to unlock the potential of the Alaskan seaweed sector.
Leveraging its proprietary data platform, Marine Biologics seeks to tap into Alaska's regenerative macroalgae farming network to commercialise sustainable compounds and ingredients. While over 10,000 species of macroalgae exist on the planet, fewer than 15 species are actively farmed for commercial use globally. Through this project, Marine Biologics aims to unlock untapped potential in recently domesticated species including dragon kelp (Eualaria fistulosa), split kelp (Hedophyllum nigripes), and bull kelp (Nereocystis luetkeana).
“This partnership opens the door for Alaskan macroalgae to drive innovation in sustainable ingredients. Our goal is to provide the data and technology needed to scale this new frontier,” said Patrick Griffin, Marine Biologics’ CEO, in a press release.
“Partnerships with innovators like Marine Biologics are helping to build Alaska’s seaweed sector into a robust and sustainable source of unique, functional ingredients for the food industry and beyond,” added Lexa Myer, owner of Alaska Ocean Farms.
Working alongside the Kodiak Seafood and Marine Science Center, the team will focus on fast-tracking the extraction and analysis of high-value compounds, aiming to meet growing demand for clean-label, sustainable solutions across industries.
